The Kenya Medical Supplies Authority (KEMSA)on Tuesday assured pharmaceutical, nursing and medical stakeholders that reforms at the Authority have started in earnest.
In a statement, the CEO Terry Ramadhani said the reforms will be geared at repositioning the Authority as an effective health products and technologies (HPTs) supply chain solutions provider in the local public healthcare space.
She said KEMSA is banking on the support of its stakeholders and will keep on consulting with them in its operations.
Ramadhani was speaking when she received a delegation from the Pharmaceutical Society of Kenya (PSK), Kenya Medical Association (KMA), Kenya Dentists Association and the National Nurses Association of Kenya (NNA-Kenya).
"The KEMSA management and staff teams are working hard to drive operational excellence by ensuring that we provide effective and efficient services to our customers," Ramadhani said.
"As healthcare stakeholders, we commit to working together with the KEMSA teams to provide technical and professional support, and ensure that the reforms are smoothly implemented," PSK chair Daniella Munene said.
She said healthcare professionals have a social contract to ensure good health outcomes and will continue to champion the interests of the public.
"We have had a fruitful engagement with KEMSA, and we are reassured that the Authority is on a restructuring path to meet its statutory mandate," she said.
The Authority said the reforms are gaining momentum after it successfully managed to reduce its order turnaround time (TAT) from 46 days in February 2021 to 14 days at the end of April 2022.
"The Authority is also on course to collect more than Sh2.7 Billion owed by County governments as part of a stakeholder engagement focused credit management strategy," it said.
Under the new KEMSA Credit management strategy, the Authority has set a target to collect at least Sh500million monthly in outstanding dues from County governments to boost its service delivery capacity.
